News & Updates

Show Multimedia Only

Atrial fibrillation and COVID-19: An expert’s insights

06 Dec 2024

COVID-19 infection is not a simple respiratory illness. The damage set off by the virus is systemic, affecting not only the lungs but multiple organs, including the heart. At a Pfizer-sponsored symposium held at AFCC 2024 in Singapore, Dr William Kristanto, cardiologist at Cardiac Care Partners, Mount Elizabeth Medical Centre, Singapore, talked about atrial fibrillation and COVID-19, including the use of oral antiviral nirmatrelvir/ritonavir in adults at high risk for severe disease.

Atrial fibrillation and COVID-19: An expert’s insights

06 Dec 2024

Original New Drug Application Approvals by US FDA (16-30 November 2024)

06 Dec 2024

New drug applications approved by US FDA as of 16-30 November 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 November 2024)

06 Dec 2024

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

05 Dec 2024 by

For individuals with type 2 diabetes mellitus (T2DM), the earlier the age at diagnosis, the higher the likelihood of subsequent coronary heart disease (CHD), stroke, cancer, and all-cause death, as shown in a study.

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

05 Dec 2024

Treatment inequality persists in individuals with AUD

05 Dec 2024

Racial/ethnic and socioeconomic disparities exist in the treatment of individuals with alcohol use disorder (AUD), a study has found.

Treatment inequality persists in individuals with AUD

05 Dec 2024

TRT shows promise as adjunct treatment in rehabilitating ICU patients

05 Dec 2024 by

Testosterone replacement therapy (TRT) has the potential to be an effective adjunct treatment in the rehabilitation of critically ill patients with intensive care unit (ICU)-associated weakness (AW) and hospital-associated deconditioning (HAD), according to a Singapore study.

TRT shows promise as adjunct treatment in rehabilitating ICU patients

05 Dec 2024

Histotripsy 2.0 available for liver and breast cancer clinical trials in HK

05 Dec 2024 by

Asia’s first histotripsy 2.0 system, introduced at the Chinese University Hong Kong (CUHK) recently, will be used in clinical trials to treat liver cancer patients from early 2025. The novel focal therapy will also be evaluated in patients with early-stage breast cancer.

Histotripsy 2.0 available for liver and breast cancer clinical trials in HK

05 Dec 2024

What drives the beneficial effects of tirzepatide on glycaemic control?

05 Dec 2024

Use of tirzepatide results in better glycaemic control when compared with semaglutide, as shown by improved fasting glucose and glucose excursion control brought about by improvements in insulin secretion rate (ISR), insulin sensitivity, and glucagon suppression, according to a study.

What drives the beneficial effects of tirzepatide on glycaemic control?

05 Dec 2024

Exercise linked to lower falls risk among people with cognitive frailty

05 Dec 2024

People with cognitive frailty are at increased risk of falls, but the good news is that exercise helps improve physical function and reduce this risk, according to a study.

Exercise linked to lower falls risk among people with cognitive frailty

05 Dec 2024

Benralizumab offers relief during eosinophilic asthma, COPD flare-ups

04 Dec 2024 by

A single subcutaneous injection of benralizumab, administered alone or in combination with glucocorticoids, helps minimize treatment failure and improve symptoms in patients with an eosinophilic exacerbation of asthma or chronic obstructive pulmonary disorder (COPD), as shown in the phase II ABRA trial.

Benralizumab offers relief during eosinophilic asthma, COPD flare-ups

04 Dec 2024

Crowding, mobility predict TB infection among kids

04 Dec 2024

A high prevalence of tuberculosis (TB) infection is seen among children and adolescents residing in rural Uganda, a study has found. Crowding and mobility are some of the factors associated with TB risk.

Crowding, mobility predict TB infection among kids

04 Dec 2024

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Atrial fibrillation and COVID-19: An expert’s insights

Atrial fibrillation and COVID-19: An expert’s insights

Original New Drug Application Approvals by US FDA (16-30 November 2024)

Original New Drug Application Approvals by US FDA (16-30 November 2024)

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

Treatment inequality persists in individuals with AUD

Treatment inequality persists in individuals with AUD

TRT shows promise as adjunct treatment in rehabilitating ICU patients

TRT shows promise as adjunct treatment in rehabilitating ICU patients

Histotripsy 2.0 available for liver and breast cancer clinical trials in HK

Histotripsy 2.0 available for liver and breast cancer clinical trials in HK

What drives the beneficial effects of tirzepatide on glycaemic control?

What drives the beneficial effects of tirzepatide on glycaemic control?

Exercise linked to lower falls risk among people with cognitive frailty

Exercise linked to lower falls risk among people with cognitive frailty

Benralizumab offers relief during eosinophilic asthma, COPD flare-ups

Benralizumab offers relief during eosinophilic asthma, COPD flare-ups

Crowding, mobility predict TB infection among kids

Crowding, mobility predict TB infection among kids